Capital Research Global Investors 13D and 13G filings for GE HealthCare Technologies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-06 11:26 am Sale | 2025-05-30 | 13G | GE HealthCare Technologies Inc. GEHC | Capital Research Global Investors | 21,960,815 4.800% | -29,234,253 (-57.10%) | Filing |
| 2025-05-13 11:32 am Sale | 2025-03-31 | 13G | GE HealthCare Technologies Inc. GEHC | Capital Research Global Investors | 51,195,068 11.200% | -7,028,870 (-12.07%) | Filing |
| 2024-11-12 12:53 pm Purchase | 2024-11-07 | 13G | GE HealthCare Technologies Inc. GEHC | Capital Research Global Investors | 58,223,938 12.700% | 6,879,219 (+13.40%) | Filing |
| 2024-02-09 5:46 pm Purchase | 2024-02-07 | 13G | GE HealthCare Technologies Inc. GEHC | Capital Research Global Investors | 51,344,719 11.300% | 3,824,608 (+8.05%) | Filing |
| 2023-05-10 11:16 am Purchase | 2023-05-10 | 13G | GE HealthCare Technologies Inc. GEHC | Capital Research Global Investors | 47,520,111 10.500% | 47,520,111 (New Position) | Filing |